With the advancement in technology and in people’s lifestyle, the cases of genetic disorder or abnormalities have increased significantly. Simultaneously, there has been advancement in the healthcare technology to tackle the modern age problems. Prenatal testing and newborn screening is the most modernized trends in the healthcare industry with a tremendous level of progress in the last few years. The high fetal mortality rate and advancement in healthcare technology are the factors responsible for the growth of prenatal and newborn screening market. The global prenatal and newborn screening market is expected to reach $10.63 billion by the end of 2022. The gradual rise in the new prenatal diagnosis and newborn screening tests is attributed to the emergence of advanced technologies such as next generation sequencing, high throughput screening, and cell free fetal DNA.
The U.S. government has approved prenatal testing and newborn screening in all of its states, and is investing more in the prenatal market. Similarly other developed and emerging countries are also designing their healthcare policies in order to include and support prenatal testing and newborn screening. All of these factors are driving the global prenatal testing and newborn screening market towards growth. Prenatal testing is dominating the market as compared to newborn screening, and is expected to grow at a CAGR of 27.98% from 2016 to 2022. Diagnosis technologies hold the largest market share and are expected to grow at a CAGR of 26.54% from 2016 to 2022. There are two techniques to this, invasive and non-invasive, and going by market trends, non-invasive prenatal testing is gaining momentum in the market.
With different lifestyle preferences, people acquire various habits, which may include smoking and drinking, which has an adverse effect on health. Beside these, modern lifestyle has become a host to myriads of problems such as obesity, increasing maternal age, and genetic disorders. The modern age problems are becoming a huge factors in the growth and popularity of global prenatal testing and newborn screening market.
North America leads the global prenatal and newborn screening market in terms of revenue generation and is expected to grow at a CAGR of 23.36% from 2016 to 2022. North America is closely followed by European region which will also witness a significant growth in the coming years. There is a prevalence of genetic disorders in the U.S., the U.K., Japan and India, hence, the market is expected to show an exponential growth in these regions. Moreover, the focus of the APAC region is on the development of technology and introduction of new advanced tools in the field of prenatal and newborn care in order to develop specific tests and solutions.
BIS Healthcare has compiled an extensive market research report on ‘Global Prenatal Testing and Newborn Screening Market: 2016-2022’. The market analysis report provides an in-depth analysis of the key development strategies, marketing strategies and market trend dynamics which includes drivers, restraints and opportunities prevailing in the industry.
For further queries, please write to us at [email protected] or call us at: +1 650 228 0182.